Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477373
Status:
COMPLETED
Last Update Posted:
2008-12-19
First Post:
2007-05-22
Brief Title:
Gulf Evaluation of VAlproate Depakine Chrono in maNia Study
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Gulf Evaluation of VAlproate Depakine Chrono in maNia Study
Status:
COMPLETED
Status Verified Date:
2008-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GEVANS
Brief Summary:
To assess the efficacy of Di-valproate in Bipolar I patients suffering from a manic episode according to DSM IV APA 1994 over a 12 weeks period of treatment
To evaluate the clinical safety of Di-valproate
To evaluate the clinical safety of Di-valproate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None